Intelligent Business Systems (IBS) and the Gujarat government recently signed a MoU to partner in the Gujarat State Biotechnology Mission.

The company's Centre for Informatics specializes in research and data analysis, which can be extended to provide an analytical insight into biological data and utilities to aid the scientific and commercial community in the understanding of genomic and proteomic data.

The Center for Informatics will collaborate with academia on problems to improve medication and healthcare delivery.

The partnership is aimed at streamlining data such as:

* Individuals responding adversely to one or more drugs,
* Predicting disease and treatment outcomes,
* Improved economic and practical efficiencies in healthcare delivery,
* Computationally complete genome sequence analysis and comparative genomics,
* Development of intelligent systems for genome,
* Protein interaction maps using gene fusion events,
* Pattern discovery,
* Evolution of the transcriptional machinery,
* Development of standards for genome sequence annotation,
* Document clustering and information extraction from biological text,
* Precocious diagnosis of life-threatening disease,

As per the MoU, IBS will provide bio-informatics and biotechnology research based solutions along with Shanku's group.

Gujarat is the first state in India to set up a Biotechnology Solutions Venture aimed at research outsourcing. IBS will deal with computer-aided drug discovery, drug interaction and bio-analysis. Shanku's group will invest Rs 40 crore for the venture.

Speaking on the occasion, Kaustubh Chokshi, CEO & co-founder, IBS, said, "Gujarat with its very strong pharma, healthcare and agriculture sectors, offers an ideal platform to venture into the emerging biotechnology industry."